Here, we explored how miR-139-5p involves in regulating depression and hypothesized that miR-139-5p could activate the BDNF-TrkB pathway to exert antidepressant-like effects, with a hope to find new depression drug targets. Here, NTRK2 is linked to depressive symptom measurement.